ReviewFrontiers in oncology2021

Dual Targeting of Multiple Myeloma Stem Cells and Myeloid-Derived Suppressor Cells for Treatment of Chemotherapy-Resistant Multiple Myeloma.

Fatih M UckunPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.